Litcius/Paper detail

Humoral response to COVID-19 vaccination in MS patients on disease modifying therapy: Immune profiles and clinical outcomes

Kathryn B. Holroyd, Brian C. Healy, Sarah Conway, Maria K. Houtchens, Rohit Bakshi, Shamik Bhattacharyya, Gauruv Bose, Kristin Galetta, Tamara Kaplan, Christopher Severson, Tarun Singhal, Lynn Stazzone, Jonathan Zurawski, Mariann Polgar‐Turcsanyi, Shrishti Saxena, Anu Paul, Bonnie I. Glanz, Howard L. Weiner, Tanuja Chitnis

2022Multiple Sclerosis and Related Disorders32 citationsDOIOpen Access PDF

Topics & Concepts

MedicineFingolimodNatalizumabMultiple sclerosisImmunologyVaccinationRituximabInternal medicineAntibodyMultiple Sclerosis Research StudiesSARS-CoV-2 and COVID-19 ResearchPeripheral Neuropathies and Disorders
Humoral response to COVID-19 vaccination in MS patients on disease modifying therapy: Immune profiles and clinical outcomes | Litcius